	Suspected Pembrolizumab-Associated Perinuclear Antineutrophil Cytoplasmic Antibody (p-ANCA) Vasculitis With Progressive Kidney Injury in a Patient With Metastatic Renal Cell Carcinoma and Limited Renal Reserve: A Diagnostic Challenge. Cureus Goshtaseb R, Luu Y, Sarmosyan K, Lopez L, Drakaki A. PMID: 42780982 [PubMed]
	Progression-free survival and objective response rate as a surrogate end point for overall survival in metastatic renal cell carcinoma: A systematic review and meta-analysis. Cancer Leong R, Chen D, Almasri L, Lum N, Xiao K, Soleimani M, Kollmannsberger CK, Raman S. PMID: 42779347 [PubMed - indexed for MEDLINE]
	Impact of BRCA alterations on Androgen Receptor pathway inhibition treatment outcome in advanced prostate cancer. Cancer Res Commun Chaudhary R, Urtishak KA, Gormley M, Lopez-Gitlitz A, Mundle S, Santiago-Walker A, McCarthy S, Shen F, Gotto GT. PMID: 42779090 [PubMed - as supplied by publisher]
	Giant Well-Differentiated Liposarcoma of the Spermatic Cord Associated With Inguinal Hernia: Clinical Insights From a Case Report. Am J Case Rep Chrz K, Hoskovec D, Kr, Dämmrich ME, Klobu. PMID: 42779088 [PubMed - indexed for MEDLINE]
	Systematic versus perilesional sampling in transperineal MRI-fusion biopsy: is perilesional sampling ready for prime time? A high-volume center analysis. World J Surg Oncol Seebold A, Büttner T, Ellinger J, Kristiansen G, Bernhardt M, Isaak A, Hoffmann C, Luetkens JA, Ritter M, Krausewitz P. PMID: 42778928 [PubMed - indexed for MEDLINE]
	Ferroptosis at the Metabolic-Immune Interface in Metastatic Castration-Resistant Prostate Cancer: Mechanistic Evidence, Translational Gaps, and Combination Strategies. Ann Surg Oncol Chen CC, Wang CJ, Lin HY. PMID: 42778841 [PubMed - as supplied by publisher]
	PHI for adverse pathology and PHI density for upgrading: two complementary predictors in localized prostate cancer. Prostate Cancer Prostatic Dis Terracciano D, Pellegrino F, Fiorenza M, Polito C, Sirica R, Fallara G, Bianchi R, Chierigo F, Maggi M, Tozzi M, Jannello LMI, Santangelo E, Martorello V, Triggiani A, Crocetto F, Imbimbo C, Del Giudice F, Barone B, Cincione A, Autorino R, De Nunzio C, Ferro M. PMID: 42778618 [PubMed - as supplied by publisher]
	Safety profile of BCG with or without immunotherapy in non-muscle-invasive bladder cancer (NMIBC): a systematic review and meta-analysis. ESMO Open Ciccarese C, Occhipinti D, Troisi P, Shore ND, De Santis M, Gontero P, Stenzl A, Assumma ST, Racioppi M, Powles T, Rocco B, Iacovelli R. PMID: 42777327 [PubMed - as supplied by publisher]
	Steroidogenesis inhibitor ODM-209 for metastatic castration-resistant prostate cancer and advanced breast cancer: Results from the first-in-human STESIDES study. Eur J Cancer Bernard-Tessier A, Spanggaard I, Utriainen T, Tanner M, Rohrberg K, Naoun N, Ikonen T, Pohjanjousi P, Garratt C, Poehlein C, Fizazi K. PMID: 42777289 [PubMed - as supplied by publisher]
	Long-term outcomes and prognostic factors in pediatric Wilms tumor: a 47-year single-center experience. Turk J Pediatr Dinçer OS, Uygun A, Da, Ö, Kartal . PMID: 42777193 [PubMed - indexed for MEDLINE]
	Upfront Biparametric MRI for Prostate Cancer Screening: Experience in 618 Korean Men Outside of a Clinical Trial Setting. AJR Am J Roentgenol Joo Y, Tse JR, Yoon J, Jung DC, Oh YT, Park JH. PMID: 42776580 [PubMed - as supplied by publisher]
	GLG1 in cancer-associated fibroblasts promotes bladder cancer growth while limiting tumor apoptosis. Apoptosis Liu J, Zhou Z, Zhang B, Liu R, Zhang Y. PMID: 42776300 [PubMed - indexed for MEDLINE]
	Gut-prostate axis in prostate cancer: microbiome signatures, mechanistic insights, and therapeutic opportunities. Front Cell Infect Microbiol Wang K, Tang Q, Fan W, Su Q. PMID: 42775139 [PubMed - indexed for MEDLINE]
	Comparing diagnostic prostate cancer biomarkers using a framework of clinically meaningful criteria. BJUI Compass Wang S, Nabavizadeh B, Ramaswamy A, Davuluri M, Zhang TR, Tzeng M, Feiertag N, Hu JC. PMID: 42774974 [PubMed]
	Tertiary lymphoid structures in urothelial carcinoma: bridging spatial architecture with therapeutic vulnerability in the post-BCG era. Front Immunol Wei X, Pei X, Yu S. PMID: 42774854 [PubMed - indexed for MEDLINE]
	Correction to "Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study)". BJU Int PMID: 42773819 [PubMed - as supplied by publisher]
	Timing of Radiographic Progression Relative to Prostate-Specific Antigen Kinetics in Patients with Metastatic Castration-Sensitive Prostate Cancer Receiving Upfront Androgen Receptor Signaling Inhibitor Therapy. Urol J Nakayama A, Ikezoe E, Inoue M, Tsujioka H, Nirazuka A, Izumi K, Setoguchi K, Saito K. PMID: 42773770 [PubMed - indexed for MEDLINE]
	Ileum vs Colon for Neobladder Reconstruction After Radical Cystectomy: A Systematic Review and Meta-Analysis. Urol J Li Y, Liu Y. PMID: 42773766 [PubMed - indexed for MEDLINE]
	Epidermoid Cyst of the Ureter Mimicking Recurrent Urothelial Carcinoma: A Case Report and Brief Literature Review. Am J Case Rep Halalsheh OM, Hulliel AF, Abualasal A, Aldeqes MI, Obeid A, Sharayah M, Al-Khatib S. PMID: 42773630 [PubMed - indexed for MEDLINE]
	Associations of Anatomical Location and Reader Experience With the Diagnostic Performance of Multiparametric MRI-Derived VI-RADS for Muscle Invasive Bladder Cancer: A Multicenter Multireader Study. J Magn Reson Imaging Wang X, Sun F, Hu J, Huang X, Du S, Wen Z, Lin F. PMID: 42773621 [PubMed - as supplied by publisher]

Articles 1 - 20 / 181652

Page 1 of 9083



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy